Zobrazeno 1 - 10
of 29
pro vyhledávání: '"Hilary, Haines"'
Autor:
Astrid Wintering, Anna Hecht, Julia Meyer, Eric B. Wong, Juwita Hübner, Sydney Abelson, Kira Feldman, Vanessa E. Kennedy, Cheryl A.C. Peretz, Deborah L. French, Jean Ann Maguire, Chintan Jobaliya, Marta Rojas Vasquez, Sunil Desai, Robin Dulman, Eneida Nemecek, Hilary Haines, Mahmoud Hammad, Alaa El Haddad, Scott C. Kogan, Zied Abdullaev, Farid F. Chehab, Sarah K. Tasian, Catherine C. Smith, Mignon L. Loh, Elliot Stieglitz
Publikováno v:
Haematologica, Vol 999, Iss 1 (2023)
Mutations in five canonical Ras pathway genes (NF1, NRAS, KRAS, PTPN11 and CBL) are detected in nearly 90% of patients with juvenile myelomonocytic leukemia (JMML), a frequently fatal malignant neoplasm of early childhood. In this report, we describe
Externí odkaz:
https://doaj.org/article/6b7a3df1a4054f309e85875af70a1441
Autor:
Kimberly A. Kasow, Jennifer A. Krajewski, Hilary Haines, Dr. Jennifer Joi Jaroscak, Michael Kent, Alexander Ngwube, Timothy S. Olson, Shalini Shenoy, Alfred P. Gillio, Elizabeth O. Stenger, Gabrielle Dean, Ann E Haight, John Horan, Emily Riehm Meier
Publikováno v:
Transplantation and Cellular Therapy. 29:S293-S294
Autor:
T. Prescott Atkinson, Courtney B. Crayne, Esraa M. Eloseily, Peter Weiser, Melissa L. Mannion, Hilary Haines, Randy Q. Cron, Matthew L. Stoll, Timothy Beukelman
Publikováno v:
Arthritis & Rheumatology. 72:326-334
OBJECTIVE To assess the benefit of the recombinant human interleukin-1 receptor antagonist anakinra in treating pediatric patients with secondary hemophagocytic lymphohistiocytosis (HLH)/macrophage activation syndrome (MAS) associated with rheumatic
Autor:
Emily Mixon, Aditi Dhir, Teresa Meadows, Joseph H. Chewning, Justin Kim, Lisa Beatty, Karen B. Fowler, Susmita Murthy, Hilary Haines, Jarrod Gage, Frederick D. Goldman, Aman Wadhwa
Publikováno v:
Journal of pediatric hematology/oncology. 44(2)
Sinusoidal obstruction syndrome/veno-occlusive disease (SOS/VOD) posthematopoietic stem cell transplantation (HSCT) is often diagnosed using the modified Seattle (MS) or European Society for Blood and Marrow Transplantation (EBMT) criteria. We hypoth
Autor:
Alexia Adams, Sanjay P Ahuja, Alfred P. Gillio, Roberta H. Adams, Lisa Eidenschink Brodersen, Sureyya Savasan, Mingwei Fei, Michael R. Loken, Michael A. Pulsipher, Kwang Woo Ahn, Morris Kletzel, David A. Jacobsohn, Pierre Teira, Barbara Bambach, Jeffrey H. Davis, David C. Delgado, Ann E. Haight, Reggie E. Duerst, Allen R. Chen, Mehmet Ozkaynak, Christopher C. Dvorak, Kimberly A. Kasow, Soheil Meshinchi, Troy C. Quigg, Madhu Gowda, Brent R. Logan, Julie-An Talano, Kirk R. Schultz, Victor Lewis, Bronwen E. Shaw, Michael Boyer, David Mitchell, David M. Loeb, Albert Kheradpour, Andrew C. Harris, Hilary Haines, Eneida R. Nemecek, Amy K. Keating, Shalini Shenoy, Robert J. Greiner, Aleksandra Petrovic, Marie Olszewski, Paul L. Martin, Terry J. Fry, Michelle Hudspeth, Alexandra Cheerva, Sana Khan, Monica Bhatia, Steven P. Margossian
Publikováno v:
Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation, vol 24, iss 10
We enrolled 150 patients in a prospective multi-center study of children with acute myeloid leukemia undergoing hematopoietic stem cell transplant (HSCT) comparing detection of measurable residual (MRD) disease by a “Difference from Normal” flow
Autor:
Hilary Haines, Emily Mixon, Aditi Dhir, Lisa Beatty, Teresa Meadows, Justin Kim, Susmita Murthy, Frederick D. Goldman, Joseph H. Chewning, Karen B. Fowler, Jarrod Gage
Publikováno v:
Biology of Blood and Marrow Transplantation. 26:S147-S148
Background Veno-occlusive disease (VOD) is a serious complication of hematopoietic stem cell transplant (HSCT) and is associated with significant mortality. There are published clinical criteria applied for diagnosis, including Baltimore, modified Se
Autor:
Lakshmanan Krishnamurti, Mary M. Horowitz, Mark C. Walters, Martin Andreansky, John E. Levine, Allistair Abraham, David A. Margolis, Ann E. Haight, Jennifer Joi Jaroscak, Iris D. Gersten, Kamar Godder, Naynesh Kamani, Julie A. Panepinto, Kimberly A. Kasow, Shalini Shenoy, Joel A. Brochstein, Jignesh Dalal, Hillard M. Lazarus, Brent R. Logan, Lolie C. Yu, Monica Bhatia, Sonali Chaudhury, Gail Megason, Juan Wu, Nancy L. DiFronzo, Mary Eapen, Michael A. Pulsipher, Hilary Haines, Kathryn S. Leung
Publikováno v:
Blood. 128:2561-2567
Children with sickle cell disease experience organ damage, impaired quality of life, and premature mortality. Allogeneic bone marrow transplant from an HLA-matched sibling can halt disease progression but is limited by donor availability. A Blood and
Autor:
Lisa R. Young, Chrysi Kanellopoulou, Kejian Zhang, Shannon Nortman, Hilary Haines, Jill M. Fritz, Jason D. Hughes, Susan Price, Michael J. Lenardo, Wei Lu, Yu Zhang, Diane Kissell, Helen C. Su, Rebecca A. Marsh, Vijaya Chaturvedi, Michael B. Jordan, Jack J. Bleesing, Zhiduo Liu, Michael C. Stephens, Joshua J McElwee, Peter Mustillo, Lixin Zheng, Elif Karakoc-Aydiner, Helen F. Matthews, Jun Mo, V. Koneti Rao, Bernice Lo, Alexandra H. Filipovich, Kasper Hoebe, Cesar M. Rueda, Ammar Husami, Claire A. Chougnet, Qian Zhang
Publikováno v:
Science. 349:436-440
Trafficking from bedside to bench Typically in translational research, a discovery in cell or molecular biology is later exploited to improve patient care. Occasionally, information flows in the opposite direction. Lo et al. found that patients with
Autor:
Hilary Haines, Lindsey Hornung, Rebecca A. Marsh, Stella M. Davies, Jack J. Bleesing, Michael B. Jordan, Alexandra H. Filipovich
Publikováno v:
Biology of Blood and Marrow Transplantation. 21:288-292
Mixed donor chimerism is increasingly common in the pediatric hematopoietic stem cell transplantation (HSCT) setting because of the increased use of reduced-intensity preparative regimens for nonmalignant diseases. Donor lymphocyte infusion (DLI) is
Autor:
Joseph H. Chewning, H H Buchanan, Inmaculada Aban, Frederick D. Goldman, R Brown, Hilary Haines
Publikováno v:
Bone marrow transplantation. 52(11)